|
⚲
|
| Keyboard |
| Holmes E Carmack
✚
|
|
|---|---|
| CIK # | 0001259720 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001259720] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Holmes E Carmack | |
| Plus Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Plus Therapeutics Inc CYTX
Restricted Stock Award (Common Stock)
|
2014-05-19 | Grant | 2,867 | $0.00 | |
|
Plus Therapeutics Inc CYTX
Non-Qualified Stock Option (Right to Buy) · derivative
|
2014-01-01 | Grant | 16,030 | $0.00 | |
|
Plus Therapeutics Inc CYTX
Restricted Stock Award (Common Stock)
|
2014-01-01 | Grant | 10,550 | $0.00 | |
|
Plus Therapeutics Inc CYTX
Non-Qualified Stock Option (Right to Buy) · derivative
|
2013-01-01 | Grant | 6,100 | $0.00 | |
|
Plus Therapeutics Inc CYTX
Restricted Stock Award (Common Stock)
|
2013-01-01 | Grant | 6,100 | $0.00 | |
|
Plus Therapeutics Inc CYTX
Restricted Stock Award (Common Stock)
|
2012-01-01 | Grant | 10,000 | $0.00 | |
|
Plus Therapeutics Inc CYTX
Non-Qualified Stock Option · derivative
|
2012-01-01 | Grant | 15,000 | $0.00 |